- Home
- LEA vs SLNO Comparison
LEA vs SLNO Comparison
Compare LEA & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEA
- SLNO
- Stock Information
- Founded
- LEA 1917
- SLNO 1999
- Country
- LEA United States
- SLNO United States
- Employees
- LEA N/A
- SLNO N/A
- Industry
- LEA Auto Parts:O.E.M.
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LEA Consumer Discretionary
- SLNO Health Care
- Exchange
- LEA Nasdaq
- SLNO Nasdaq
- Market Cap
- LEA 4.7B
- SLNO 3.8B
- IPO Year
- LEA N/A
- SLNO 2014
- Fundamental
- Price
- LEA $92.92
- SLNO $86.00
- Analyst Decision
- LEA Buy
- SLNO Strong Buy
- Analyst Count
- LEA 11
- SLNO 9
- Target Price
- LEA $115.36
- SLNO $105.11
- AVG Volume (30 Days)
- LEA 755.4K
- SLNO 1.5M
- Earning Date
- LEA 07-25-2025
- SLNO 08-06-2025
- Dividend Yield
- LEA 3.31%
- SLNO N/A
- EPS Growth
- LEA N/A
- SLNO N/A
- EPS
- LEA 8.57
- SLNO N/A
- Revenue
- LEA $22,889,700,000.00
- SLNO N/A
- Revenue This Year
- LEA N/A
- SLNO N/A
- Revenue Next Year
- LEA $3.30
- SLNO $506.77
- P/E Ratio
- LEA $10.86
- SLNO N/A
- Revenue Growth
- LEA N/A
- SLNO N/A
- 52 Week Low
- LEA $73.85
- SLNO $41.50
- 52 Week High
- LEA $123.51
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- LEA 34.95
- SLNO 54.38
- Support Level
- LEA $97.51
- SLNO $83.53
- Resistance Level
- LEA $109.38
- SLNO $89.12
- Average True Range (ATR)
- LEA 2.58
- SLNO 2.65
- MACD
- LEA -1.99
- SLNO -0.34
- Stochastic Oscillator
- LEA 5.89
- SLNO 56.91
About LEA Lear Corporation
Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns most of its revenue from the seating segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.